iGEN
Visit IGEN World Explore IGEN Expo
EXPLORE UPGRADE PLANS
BREAKING
India seeks to cut reliance on imported strawberry varieties with indigenous breeding Burnham Confirms Pragmatic North Sea Oil Stance in Trump Call, Fueling Drilling Debate Leaked Memo Links Iranian Hackers to Minnesota Water Utility Cyberattacks Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift India seeks to cut reliance on imported strawberry varieties with indigenous breeding Burnham Confirms Pragmatic North Sea Oil Stance in Trump Call, Fueling Drilling Debate Leaked Memo Links Iranian Hackers to Minnesota Water Utility Cyberattacks Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift
Home ›› Topics ›› biotech

Topic

biotech

2 stories
Peptide Manufacturing Capacity Investments Surge Ahead of FDA Reclassification Decision Manufacturing
Pharmaceuticals #peptides#pharmaceuticals

Peptide Manufacturing Capacity Investments Surge Ahead of FDA Reclassification Decision

Telehealth companies and compounding pharmacies are investing in peptide manufacturing capacity ahead of a pivotal FDA reclassification meeting on July 23-24. Hims & Hers Health purchased a peptide manufacturing facility in February 2025, while Olympia Pharmaceuticals has spent heavily on formula development. Testing investments exceed $100,000 per product.

Jul 21, 2026 1 source
Life Biosciences Begins Human Trials for Vision Restoration Technology
Startups #longevity#startup

Life Biosciences Begins Human Trials for Vision Restoration

Life Biosciences has initiated human trials for ER-100, a drug aimed at reversing age-related sight loss. The trial will assess safety and side effects in patients with glaucoma and NAION.

Jun 10, 2026 1 source